Nanovaccine administration route is critical to obtain pertinent iNKt cell help for robust anti-tumor T and B cell responses

DÖLEN, Y., VALENTE, M., TAGIT, O., JÄGER, E., VAN DINTHER, E. A. W., VAN RIESSEN, N. K., HRUBÝ, M., GILEADI, U., CERUNDOLO, V., FIGDOR, C. G. Nanovaccine administration route is critical to obtain pertinent iNKt cell help for robust anti-tumor T and B cell responses. Oncoimmunology. 2020, 9(1), 1-14), 1738813. ISSN 2162-402X. E-ISSN 2162-402X. Available: doi: 10.1080/2162402X.2020.1738813.